Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT01037439 |
Other study ID # |
MAEssenASV |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 2008 |
Est. completion date |
December 2009 |
Study information
Verified date |
February 2021 |
Source |
ResMed |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The objective of this study is to compare the modified adaptive servoventilation control
algorithm of the with the standardised algorithms of routinely-used servoventilation
processes (AutoSet CS2) in terms of the effect on obstructive and central events. The aim is
to normalise breathing during sleep and hence eliminate the sleep-related breathing disorder,
resulting in even more effective treatment of nocturnal breathing disorders in patients with
cardiovascular diseases and sleep apnoea, to ensure optimum therapy success.
Description:
Patients with cardiovascular disorders frequently suffer from sleep-related respiratory
disorders (SRRD), such as obstructive sleep apnea (OSA) or a specific form of central sleep
apnea, Cheyne-Stokes breathing (CSB, periodic breathing). However there is also a significant
incidence of complex nocturnal breathing disorders, with both obstructive and central
components. Sleep-related breathing disorders of this kind cause decreases in arterial oxygen
saturation through brief hypopneas and apneas. Disturbed breathing also causes the patient to
wake frequently during the night (arousals), usually during the hyperventilatory phase of
CSB. Repeated arousals cause fragmentation of sleep, and therefore a deep sleep deficit. This
leads to increased sleepiness during the day and impaired cognitive performance.
Previous studies have shown that Cheyne-Stokes breathing can be treated effectively with
adaptive servoventilation. An enhancement to the routinely used algorithm (AutoSet CS2) has
been created which allows the algorithm to differentiate between obstructive events and
Cheyne-Stokes breathing, and better respond to apneas and hypopneas to eliminate the
sleep-related breathing disorder and normalise breathing during sleep.